Inhibition of Inflammation by a p38 MAP Kinase Targeted Cell Permeable Peptide

By  

Medicinal Chemistry, Vol. 4, Iss. 6, 2008-11 ,pp. : 597-604

Bentham Science Publishers

Access to resources Recommend Favorite

p38 MAP Kinase Inhibitors as Potential Therapeutic Drugs for Neural Diseases

By  

Central Nervous System Agents in Medicinal Chemistry (Formerly Current Medicinal Chemistry - Central Nervous System Agents), Vol. 11, Iss. 1, 2011-03 ,pp. : 45-59

Bentham Science Publishers

Access to resources Recommend Favorite

A Theoretical Investigation on the Pleiotropic Effects of Statins as p38 MAP Kinase Ligands

By  

Letters in Drug Design & Discovery, Vol. 7, Iss. 8, 2010-10 ,pp. : 546-550

Bentham Science Publishers

Access to resources Recommend Favorite

Molecular Basis for Invertebrate Innate Immune Recognition of (1→3)-&bgr;- D-Glucan as A Pathogen-Associated Molecular Pattern

By  

Current Pharmaceutical Design, Vol. 12, Iss. 32, 2006-01 ,pp. : 4155-4161

Bentham Science Publishers

Access to resources Recommend Favorite

Inhibitors and Modulators of &bgr;- and &ggr;-Secretase

By  

Current Topics in Medicinal Chemistry, Vol. 6, Iss. 4, 2006-02 ,pp. : 377-392

Bentham Science Publishers

Access to resources Recommend Favorite